The founder and four former executives of Insys Therapeutics Inc. were convicted by a federal jury in Boston in connection with bribing medical practitioners to prescribe Subsys, a sublingual spray formulation of fentanyl intended for cancer patients experiencing breakthrough pain, and for defrauding Medicare and private insurance carriers.